(Q40800348)

23 September 2017

title

Interaction of cytosine arabinoside and lovastatin in human leukemia cells (English)

1 reference

23 September 2017

1 reference

1 reference

S A Holstein

1

1 reference

23 September 2017

R J Hohl

series ordinal

2

1 reference

23 September 2017

publication date

1 August 2001

1 reference

23 September 2017

1 reference

23 September 2017

volume

25

1 reference

23 September 2017

issue

8

1 reference

23 September 2017

page(s)

651-660

1 reference

A randomized study of intermediate versus conventional-dose cytarabine as intensive induction for acute myelogenous leukaemia

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900162-4

7 January 2021

HMG-CoA reductase inhibitors for treatment of hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900162-4

7 January 2021

Protein prenylation: genes, enzymes, targets, and functions.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900162-4

7 January 2021

Potentiated antitumour effects of cisplatin and lovastatin against MmB16 melanoma in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900162-4

7 January 2021

Differential effects of monoterpenes and lovastatin on RAS processing

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900162-4

7 January 2021

Criteria for analyzing interactions between biologically active agents

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900162-4

7 January 2021

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900162-4

7 January 2021

Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900162-4

7 January 2021

Lovastatin induces growth inhibition and apoptosis in human malignant glioma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900162-4

7 January 2021

Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900162-4

7 January 2021

The leukaemic oncoproteins Bcr-Abl and Tel-Abl (ETV6/Abl) have altered substrate preferences and activate similar intracellular signalling pathways.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900162-4

7 January 2021

All ras proteins are polyisoprenylated but only some are palmitoylated

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900162-4

7 January 2021

The roles of signaling by the p42/p44 mitogen-activated protein (MAP) kinase pathway; a potential route to radio- and chemo-sensitization of tumor cells resulting in the induction of apoptosis and loss of clonogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900162-4

7 January 2021

Tumor resistance to oxidative stress: association with ras oncogene expression and reversal by lovastatin, an inhibitor of p21ras isoprenylation

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900162-4

7 January 2021

Oral cytarabine ocfosfate in acute myeloid leukemia and non-Hodgkin's lymphoma--phase I/II studies and pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900162-4

7 January 2021

Cytidine deaminase - the methodological relevance of AraC deamination for ex vivo experiments using cultured cell lines, fresh leukemic blasts, and normal bone marrow cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900162-4

7 January 2021

10.1016/S0145-2126(00)00162-4

Identifiers

DOI

1 reference

23 September 2017

1 reference